UPMC Hillman Cancer Center Investigational Drug Service — Pittsburgh, Pennsylvania

UPMC Hillman Cancer Center Investigational Drug Service is a clinical research site located in Pittsburgh, Pennsylvania, United States 15232.

Crixeo Clinical Trials Trust Score: 8/100 (FAILING). This profile has not yet been claimed by the site owner.

UPMC Hillman Cancer Center Investigational Drug Service has participated in 3 clinical trials.

Therapeutic areas: EGFRI Induced Acneiform Lesions, Advanced Solid Tumor, Metastatic Solid Tumor.

Sponsors: Lutris Pharma Ltd., Jazz Pharmaceuticals, Pfizer.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Pittsburgh

Browse all research sites in Pennsylvania · View every site in Pittsburgh

• University of Pittsburgh Cancer Institute, William M. Cooper Ambulatory Pavilion of the Hillman Cancer Center
• UPMC Presbyterian Shadyside Hospital
• University of Pittsburgh Physicians
• University of Pittsburgh Division of Pulmonary
• ENT Department, Children's Hospital of Pittsburgh
• Site US10167 University of Pittsburgh Medical Center
• University of Pittsburgh Medical Center, CHF/Transplantation Cardiology
• UPMC Children's Hospital
• Duplicate_Allegheny General Hospital /ID# 215585
• University of Pittsburgh MC /ID# 65486
• UPMC Hillman Cancer Center, Magee-Womens Hospital
• University of Pittsburgh Medical Center Department of Dermatology

Sponsor Feasibility Report

Trust Score: 8/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UPMC Hillman Cancer Center Investigational Drug Service?

UPMC Hillman Cancer Center Investigational Drug Service has a Crixeo Trust Score of 8/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UPMC Hillman Cancer Center Investigational Drug Service conducted?

UPMC Hillman Cancer Center Investigational Drug Service has 3 clinical trials on record. Their work covers EGFRI Induced Acneiform Lesions, Advanced Solid Tumor, Metastatic Solid Tumor.

Is UPMC Hillman Cancer Center Investigational Drug Service accredited by Crixeo Clinical Trials?

UPMC Hillman Cancer Center Investigational Drug Service has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about UPMC Hillman Cancer Center Investigational Drug Service?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.